Last reviewed · How we verify
NCT04693793
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
NA trial testing Education Materials and Janssen Test in Dyspnea in 219 participants. Completed in 15 October 2022.
15 September 2022
Quick facts
| Lead sponsor | Qure Healthcare, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 219 |
| Start date | 5 March 2021 |
| Primary completion | 15 September 2022 |
| Estimated completion | 15 October 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Education Materials and Janssen Test
Conditions studied
- Dyspnea — all drugs for Dyspnea →
- Unexplained Chronic Dyspnea — all drugs for Unexplained Chronic Dyspnea →
Sponsor
Qure Healthcare, LLC — full company profile →
Who can join
Eligibility, any sex, with Dyspnea or Unexplained Chronic Dyspnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dyspnea and and how the results of Janssen Pharmaceuticals' test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gaps in the Care of Pulmonary Hypertension: A Cross-Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists.
de Belen E, McConnell JW, Elwing JM, Paculdo D, et al · · 2023 · cited 3× · PMID 36628980 · DOI 10.1161/jaha.122.026413
Verify or expand the search:
- PubMed search for NCT04693793
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dyspnea
Currently open trials in the same condition.
- NCT07386444 — Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy · NA · recruiting
- NCT06807983 — LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly · NA · recruiting
- NCT07104578 — Evaluation of the Impact of Pleuropulmonary Ultrasound on the Diagnosis of Dyspnea · recruiting
- NCT07268859 — Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea · NA · recruiting
- NCT06556797 — Proof-of-concept Study on Dyspnea Analysis Via GapCO2 · recruiting
Other Qure Healthcare, LLC trials
Trials by the same sponsor.
- NCT07099001 — Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay · NA · completed
- NCT05702385 — Clinical Utility Study for Exo-PDAC · NA · withdrawn
- NCT05603299 — Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test · NA · withdrawn
- NCT05910697 — Clinical Utility of MyProstateScore 2.0 P2 · NA · terminated
- NCT05525806 — Clinical Utility Study for MyProstateScore+ · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04693793 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qure Healthcare, LLC
- Last refreshed: 7 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04693793.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing